253 related articles for article (PubMed ID: 1394063)
1. The prognostic value of Ki-67 antigen in non-Hodgkin lymphoma of Waldeyer ring and the nasal cavity.
Yamanaka N; Harabuchi Y; Kataura A
Cancer; 1992 Nov; 70(9):2342-9. PubMed ID: 1394063
[TBL] [Abstract][Full Text] [Related]
2. Malignant lymphomas of the nasal cavity and Waldeyer's ring--clinicopathologic and immunohistochemical study.
Ko YH; Lee JD; Kim CM; Kim IS; Lee MJ
J Korean Med Sci; 1992 Dec; 7(4):314-24. PubMed ID: 1299234
[TBL] [Abstract][Full Text] [Related]
3. [The advancement of image cytometry in immunohistology].
Yamanaka N
Nihon Rinsho; 1992 Oct; 50(10):2505-9. PubMed ID: 1447823
[TBL] [Abstract][Full Text] [Related]
4. Malignant lymphomas of the nasal cavity and paranasal sinuses. A clinicopathologic and immunohistochemical study.
Kojima M; Hosomura Y; Kurabayashi Y; Ohno Y; Itoh H; Yoshida K; Johshita T; Tamaki Y; Niibe H; Nakamura S
Acta Pathol Jpn; 1992 May; 42(5):333-8. PubMed ID: 1636435
[TBL] [Abstract][Full Text] [Related]
5. [Nasal and pharyngeal non-Hodgkin lymphomas and their relationship with Epstein-Barr virus: a report of 158 cases].
He YJ; Jia XS; Hasui K; Wang EH; He AG
Zhonghua Bing Li Xue Za Zhi; 2007 Feb; 36(2):94-7. PubMed ID: 17493382
[TBL] [Abstract][Full Text] [Related]
6. Assessment of proliferative activity in leukaemic bone marrow using the monoclonal antibody Ki-67.
White DM; Smith AG; Smith JL
J Clin Pathol; 1994 Mar; 47(3):209-13. PubMed ID: 8163690
[TBL] [Abstract][Full Text] [Related]
7. Proliferation in non-Hodgkin's lymphomas as determined by immunohistochemical double staining for Ki-67.
Tominaga K; Yamaguchi Y; Nozawa Y; Abe M; Wakasa H
Hematol Oncol; 1992; 10(3-4):163-9. PubMed ID: 1398512
[TBL] [Abstract][Full Text] [Related]
8. Non-Hodgkin's lymphoma of the sinonasal tract. A clinicopathologic and immunophenotypic study of 120 cases.
Abbondanzo SL; Wenig BM
Cancer; 1995 Mar; 75(6):1281-91. PubMed ID: 7882278
[TBL] [Abstract][Full Text] [Related]
9. Non-Hodgkin's lymphoma of Waldeyer's ring and nasal cavity. Clinical and immunologic aspects.
Yamanaka N; Harabuchi Y; Sambe S; Shido F; Matsuda F; Kataura A; Ishii Y; Kikuchi K
Cancer; 1985 Aug; 56(4):768-76. PubMed ID: 4016670
[TBL] [Abstract][Full Text] [Related]
10. DNA image cytometry and the expression of proliferative markers (proliferating cell nuclear antigen and Ki67) in non-Hodgkin's lymphomas.
Czader M; Porwit A; Tani E; Ost A; Mazur J; Auer G
Mod Pathol; 1995 Jan; 8(1):51-8. PubMed ID: 7731942
[TBL] [Abstract][Full Text] [Related]
11. [Correlation between the grade of histological malignancy and nuclear positivity using the AgNOR technique in 6 cases of isolated bone NHL].
Cosimi MF; Casagranda I; Porta C; Moroni M; Orsi R; Nastasi G
Sangre (Barc); 1992 Oct; 37(5):399-402. PubMed ID: 1293782
[TBL] [Abstract][Full Text] [Related]
12. Lymph node classification systems in cutaneous T-cell lymphoma. Evidence for the utility of the Working Formulation of Non-Hodgkin's Lymphomas for Clinical Usage.
Vonderheid EC; Diamond LW; van Vloten WA; Scheffer E; Meijer CJ; Cashell AW; Hardman JM; Lai SM; Hermans J; Matthews MJ
Cancer; 1994 Jan; 73(1):207-18. PubMed ID: 8275427
[TBL] [Abstract][Full Text] [Related]
13. Quantitative analysis of cellular proliferative activity in 35 T-cell non-Hodgkin's lymphomas. Use of proliferating cell nuclear antigen and Ki-67 (MIB-1) antibodies and nucleolar organizer regions.
Caulet-Maugendre S; Patey M; Granier E; Joundi A; Gentile A; Caulet T
Anal Quant Cytol Histol; 1996 Oct; 18(5):337-44. PubMed ID: 8908304
[TBL] [Abstract][Full Text] [Related]
14. Non-Hodgkin's lymphomas of childhood and adolescence: results of a treatment stratified for biologic subtypes and stage--a report of the Berlin-Frankfurt-Münster Group.
Reiter A; Schrappe M; Parwaresch R; Henze G; Müller-Weihrich S; Sauter S; Sykora KW; Ludwig WD; Gadner H; Riehm H
J Clin Oncol; 1995 Feb; 13(2):359-72. PubMed ID: 7844597
[TBL] [Abstract][Full Text] [Related]
15. [Primary non-Hodgkin's lymphoma of the nasal cavity at early stage: long-term treatment outcomes and prognostic analyses of 108 cases].
He YF; Zhang YJ; Li YH; Lin TY; Xia YF; Lu TX; Huang HQ; Jiang WQ; Xian CG; He YJ; Guan ZZ
Ai Zheng; 2006 Dec; 25(12):1538-42. PubMed ID: 17166382
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathological analysis of 501 non-Hodgkin's lymphomas in Korea according to the revised European-American classification of lymphoid neoplasms.
Lee SS; Cho KJ; Kim CW; Kang YK
Histopathology; 1999 Oct; 35(4):345-54. PubMed ID: 10564389
[TBL] [Abstract][Full Text] [Related]
17. Analysis of proliferating cell fraction determined by monoclonal antibody to M1-subunit ribonucleotide reductase and Ki-67 in relation to p53 protein expression in fine-needle aspirates from non-Hodgkin's lymphomas.
Sviatoha V; Tani E; Rassidakis G; Tribukait B; Kleina R; Skoog L
Cytopathology; 2000 Oct; 11(5):290-301. PubMed ID: 11014656
[TBL] [Abstract][Full Text] [Related]
18. Lymphomas of the breast. A clinicopathologic and immunohistochemical study of primary and secondary cases.
Cohen PL; Brooks JJ
Cancer; 1991 Mar; 67(5):1359-69. PubMed ID: 1991299
[TBL] [Abstract][Full Text] [Related]
19. [Prognostic factors of primary non-Hodgkin's lymphoma of the nasal cavity--a report of 129 cases].
Yao B; Li YX; Fang H; Jin J; Liu XF; Yu ZH
Ai Zheng; 2006 Apr; 25(4):465-70. PubMed ID: 16613682
[TBL] [Abstract][Full Text] [Related]
20. Cell proliferation in non-Hodgkin's lymphomas. Digital image analysis of Ki-67 antibody staining.
Schwartz BR; Pinkus G; Bacus S; Toder M; Weinberg DS
Am J Pathol; 1989 Feb; 134(2):327-36. PubMed ID: 2464940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]